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SI Methods 
pp-Rhod-arrestin 1 complex preparation. 
Seven residues were not fully resolved in the chain A of the recent crystal structure (PDB 
ID:5W0P)(1) including the full sequence of 324-330 in the C-tail of pp-rhod and side 
chains of residue 2075 and 2080 in the arrestin-1. We added the missing side chains using 
Swiss-pdbviewer(2), where during the process we also reconstructed the side chains. We 
built the missing sequence from 325-329 using MODELLER program(3) using the chain 
A of crystal rhod-arrestin complex (pdb ID:4ZWJ)(4). We also removed the T4L protein 
and N-acetylglucosamine that had been added to promote crystallization. To refine the 7 
added residues on the C-tail, we subjected the complex to 1000 steps of energy 
minimization using steepest descents and subsequently applied 80 cycles of temperature 
annealing over 4 ns, where all residues including the added ones on the C-tail were heated 
from 0 to 25 to 600K for 25, 100, 310, 450, and 600 over 20 ps and then cooled back to 
310 over 30 ps. During this process, all backbone atoms except for residues 324-330 in the 
C-tail were restrained with the force constant of 9.6 kcal.mol-1.Å-2 in order that the atoms 
resolved in the crystal structure not be disturbed, since we wanted only to refine the atoms 
not resolved. We embedded this refined complex in a palmitoyl-oleoyl-
phosphatidylcholine (POPC) bilayer composed of 356 POPC molecules and then solvated 
the system with ~40K water molecules. We neutralized the system and added 0.15mM 
NaCl to maintain the biological salt concentration, which resulted to a simulation box of 
123x104x138 Å3. Subsequently, we minimized the system for 5000 steps of energy 
minimization using the steepest descent algorithm and then equilibrated the complex for 
520 ps of NVT followed by 700 ps NPT simulations where positional restraints were placed 
on the heavy atoms with a force constant of 9.6 kcal.mol-1.Å-2. Then, we performed 450 ns 
of NPT simulation in which we removed the positional restraints on the heavy atoms and 
placed restraints on the backbone atoms to refine the interactions without changing the 
shape of the crystal structure. This refined complex differed from the crystal structure by 
RMSD=0.3 Å. It was used as a template for comparison and modelling of the pp-μOR-
barr2 interface. 
Modeling of human pp-μOR in complex with morphine 
First, we used the activated mouse-μOR structure [PDB ID: 5C1M](5) as a template for 
GEnSeMBLE predictions(6) to model the activated structure for the human-μOR. Briefly, 
the GEnSeMBLE procedure(6) starts with the tilts for the 7 helical TM domains of mouse-
μOR as a template and examines all possible tilts and rotations of these helices up to 10° 
for the polar angle and up to 30° for the other angles.  This leads to 13 trillion combinations 
for each of which we estimate the energy considering only pair-wise interactions between 
the seven TM, with the side chains optimized for interhelical interactions using 
SCREAM(7).Then for the 1000 predicted best combinations, we built 7-TM bundles while 
re-optimizing the side chains for interhelical interactions independently for each of the 
1000 and carrying out conjugate gradient minimization to remove bad contacts. From this 
1000 cases we selected the 25 lowest-energy packings as the ensemble for docking ligands. 
Next we predicted the binding site of morphine to each of these 25 packings using the 
DarwinDock procedure(8). Briefly, the optimum morphine conformations from the X-ray 
structure was minimized and then docked to each of the 25 packings of 7TM bundles in 
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the human-μOR. For each ligand-μOR combination, we replaced the 6 hydrophobic 
residues with Ala and then examined 50,000 poses without energy evaluations. Instead we 
group them into ~ 2000 Voronoi families using RMSD. Then we evaluated energies for the 
family heads. Then for the best 10%, we evaluated the energies of all children, from which 
we selected the best 100 by energy. Then we used SCREAM to convert back from Ala for 
the 6 hydrophobic residues so that each pose has the optimum set of side chains, which are 
different for each pose. Then we selected the best few binding poses by assessing the 
binding energy. Next we compared the 25×100=2500 binding energies using a unified 
binding site to select the best 10 structures, which we then compared to select the best 
combination of ligand-μOR coupling.  
Using MODELLER(3), we added the native sequence of the long C-tail and connected to 
the last residue of the H8 helix on human MOR. Subsequently, we phosphorylated all 
Serine and Threonine residues in the C-tail to obtain the full degree of phosphorylation. 
This human-μOR-morphine complex was used to match the DAMGO and TRV130. 
Refinement of the pp-C tail of the μOR 
To model the inactive barr2- pp- μOR-morphine complex, we started with the crystal 
structure of inactive bovine arrestin-3 (pdb ID: 3P2D)(9) to use as an input for the SWISS-
MODEL server(10) to predict the inactive structure of the human barr2 in accord with 
homology modeling. Subsequently, we superimposed the resulting structure of barr2 and 
pp-μOR-morphine separately onto the arrestin-1 and pp-rhod of our optimized pp-rhod-
arrestine1 complex, respectively. To refine the pp-C-tail conformation and the interaction 
with barr2, we subjected the complex to 1000 steps of energy minimization using the 
steepest descents algorithm and subsequently carried out 400 cycles of temperature 
annealing over 20 ns. Here all residues including the added ones on the C-tail were heated 
from 0 to 25 to 600K with the sequence of 25, 100, 310, 450, and 600 over 20 ps and then 
cooled back to 310 over 30 ps. During this process, all backbone atoms except for residues 
341-400 on the pp-C-tail, were restrained with a force constant of 9.6 kcal.mol-1.Å-2 to 
refine the interactions and side chains. In addition, we placed restraints with a force 
constant of 1.2 kcal.mol-1.Å-2 on the distances between pS357-R157barr2, pS358-K13barr2, 
pS365-R47barr2, pT366-R47barr2, pT372-K45barr2, pS395-K6barr2, and pT385-R102barr2 to 
expedite forming salt bridges between the pairs. We immersed this complex in a POPC 
bilayer composed of 356 of POPC molecules and then solvated with ~40K water 
molecules. We neutralized the system and added 0.15mM NaCl to maintain the biological 
salt concentration. This resulted in a simulation box of 123x104x138 Å3, with ~180K 
atoms. Subsequently, we minimized the system with 5000 steps of energy minimization 
using the steepest descents algorithm and subsequently equilibrated the complex by 
performing 20 ps of NVT followed by 10.2 ns of NPT simulations, where positional 
restraints were placed on the heavy atoms with a force constant of 9.6 kcal.mol-1.Å-2 which 
was gradually reduced to 0 kcal.mol-1.Å-2. Then, we performed 36.6 ns of NPT simulation 
where we removed the positional restraints on the heavy atoms but we used a set of 
harmonic restraints on the inter-helical hydrogen bonds in order to relax the protein 
structure while ensuring that the helical domains are stable and intact over the course of 
simulation. The distance between N (i+4) and C (i) atoms of the residues in the helices was 
restrained at a distance of 4.1 Å using a force constant of ~1.2 kcal.mol-1Å-2. To refine the 
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conformation of the pp-C tail, we performed several short metaMD simulations (described 
below) for an overall time of ~380ns to examine formation of several potential salt bridges 
between the phosphorylated serine and threonine residues on the C tail and the positively 
charged residues on the N-domain of barr2. The purpose of these calculations was to 
prepare the conformation of C-tail to properly interact with the N-domain of activated 
barr2. Thus, we did not fully converge these free energies. Rather, we just encouraged 
several potential salt bridges to be made by following several cycles (at least one cycle) of 
forming and breaking those salt bridges in a limited number of pathways. This procedure 
is sufficient to perturb the energy of system in reduced time scale to refine the pp-C tail 
conformation while searching for additional salt bridges that might couple tightly to the N-
domain of inactive barr2 with the pp-C tail. This technique, using short metaMD 
simulations without the need of free energy convergence, was used before to assess the 
energetics of different pathways of ligand-protein binding (11, 12).  
Once these preliminary calculations were done, we removed the inactive form of barr2 and 
replaced it with the activated form of barr2 in order to optimize the fully engaged barr2- 
pp-μOR-agonists (our desired complexes) as described below. 
Details of metaMD simulations 
To refine the conformation of pp-C tail to engage tightly the barr2, we performed several 
short metaMD simulations to encourage forming several salt bridge interactions between 
the pS and pT residues form the pp-C tail to the positively charged residues on the N-
domain.  
Starting from the pre-equilibrated structure obtained from the ~67ns of MD simulations, 
we applied the well-tempered metaMD(13) bias force on the distance between pT396(P)-
R95barr2(CZ), in which they were 25.6Å apart from each other.  
We performed a well-tempered metaMD simulation for ~88ns to promote the formation of 
the salt bridge between the pair (shown in Figure S9A), which substantially reduced the 
system energy by ~-17kcal/mol (shown in Figure S9B).  
The bias was used a Gaussian width of 1 Å, an initial Gaussian amplitude of 0.6 kcal/mol, 
a deposition period of 1.0 ps, and a bias factor of 20. To expedite the sampling process, we 
imposed a harmonic upper wall with a force constant of ~24 kcal.mol-1Å-2 at a distance of 
25.0 Å to limit the sampling space accessible during the simulation. During this calculation, 
we also introduced a harmonic restraint on the important salt bridges that were already 
formed from the previous calculations. Here, we placed a harmonic restraint on the distance 
between D179ICL2 (CG)-K134barr2 (NZ), at a distance of 3.5 Å and force constants of ~1.2 
kcal.mol-1Å-2 to ensure that this interaction is intact over the perturbations that metaMD 
calculation causes.   
We repeated the same strategy for several potential salt bridges (summarized in the Table 
S1). The well-tempered metaMD simulations were implemented using the PLUMED 
2.4.1(14). The free energy profile resulted from these calculations are represented in Figure 
S9. 
 
Modeling of pp- μOR-morphine to complex with the active barr2. 
To model the active barr2-pp-μOR-morphine complex, we used the crystal structure of 
active bovine arrestin-3 as a template for homology modeling with MODELELR(3). 
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Subsequently, we superimposed the barr2 and refined pp-μOR-morphine (from the 
previous step) structures onto the arrestin-1 and pp-rhod of the optimized pp-rhod-
arrestine1 complex, respectively. We immersed this complex in a POPC bilayer composed 
of 356 POPC molecules and then solvated it with ~40K water molecules. We neutralized 
the system and added 0.15mM NaCl to maintain the biological salt concentration, which 
resulted in a simulation box of 123x104x138 Å3 with ~180K atoms. Subsequently, we 
minimized the system for 5000 steps of steepest descents and subsequently equilibrated the 
complex by performing 1.1 ns of NVT followed by 9 ns of NPT simulations, where 
positional restraints were placed on the heavy atoms with a force constant of 9.6 kcal.mol-
1.Å-2 which was gradually reduced to 0 kcal.mol-1.Å-2. Finally, we removed all restraints 
and performed a 500 ns of NPT simulation, which was used to make Figure 2 in this paper. 
To test our model, we independently performed a new set of simulations for ~510ns where 
we reassigned the velocities.  
To test the role of the lipid anchoring from the C-edge of the barr2, we performed another 
simulation in which the C-edge of the barr2 lacked any contacts with the membrane bilayer. 
To perform this simulation, we pushed the C-edge into the water and subsequently carried 
out a ~200ns MD simulation. 
Modeling of pp-μOR-DAMGO in complex with the active barr2. 
To match DAMGO to the activated pp-μOR resulting from the previous calculation, we 
first superimposed the human pµOR to the recent activated mouse-µOR obtained by cryo-
EM (pdb id: 6DDF)(15), Needleman-Wunsch sequence alignment algorithm(16) with the 
BLOSUM-62 matrix. Then, to locate and optimize the binding interactions between 
human-µOR and DAMGO, we subjected the complex to 1000 steps of energy 
minimization with steepest descents and subsequently to 500 cycles of temperature 
annealing over 5 ns, where all residues and DAMGO were heated from 0 to 25 to 600K 
with the sequence of 25, 100, 310, 450, and 600 over 20 ps and then cooled back to 310 
over 30 ps. During this calculation, all backbone atoms of proteins and DAMGO heavy 
atoms were restrained with force constants of 9.6 and 2.4 kcal.mol-1.Å-2, respectively. 
Then, we superimposed the resulted complex pp-μOR-DAMGO onto our barr2-pp-μOR-
morphine to build the barr2-pp-μOR-DAMGO complex. We immersed this complex in a 
POPC bilayer composed of 356 of POPC molecules and then solvated with ~40K water 
molecules. We neutralized the system and then we added 0.15mM NaCl to maintain the 
biological salt concentration, which resulted in a simulation box of 123x104x138 Å3. 
(180K atoms). Subsequently, we minimized the system with 1000 steps of using steepest 
descents and subsequently equilibrated the complex with 1.1 ns of NVT followed by 2.2 
ns of NPT simulation where positional restraints were placed on the heavy atoms with a 
force constant of 9.6 kcal.mol-1.Å-2 which was gradually reduced to 0 kcal.mol-1.Å-2. 
Finally, we removed all restraints and performed a 500 ns of NPT simulation, which was 
used to make Figure 1 in this paper.  
Umbrella sampling MD for finding the activation pathway of barr2. 
To find the activation pathway of barr2, we assessed the energetics of decoupling the barr2 
from the activated complex by pulling it towards the solution inside the cell using the 
umbrella sampling method. (17, 18) We inserted the bias forces on the distance along the 
z-component between the center of mass of Cas in the pp-µOR for the residues 54-340 and 
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the center of mass of Cas in barr2. To do this, we sampled center of mass distances from 
43-64 Å using 1Å increment in the z-component, which results to 23 separate 
windows/configurations. To find these different configurations, we gradually pulled the 
barr2 away from the pp-µOR over the course of ~10 ns by applying the force constant of 
0.48 kcal.mol-1.Å-2 and a pull rate of 0.005Å.ps-1. In these windows, while the pp-µOR was 
embedded in 356 POPC molecules, the barr2 was solvated in a larger thickness of water 
including ~53K water molecules to facilitate study of barr2 penetration. Then, we added 
enough counter ions to neutralize the system and added 0.15M of NaCl on top of that. Each 
window was subsequently subjected to a 1ns of NPT simulation, where we applied the 
restraint (3.6 kcal.mol-1Å-2) on the distance between the center of mass of Cas in the pp-
µOR for the residues 54-340 and the center of mass of Cas in barr2 to relax the system and 
prepare it for the final free energy calculation. Finally, we performed a 10ns of NPT 
simulation with time step size of 2.0 fs on each window, 230ns for all windows in total, 
with applying the same restraints on the distance between the center of mass of Cas in the 
pp-µOR for the residues 54-340 and the center of mass of Cas in barr2 to evaluate the free 
energy. The free energy profile (Figure 1) was obtained by the weighted histogram analysis 
method (WHAM)(19). The statistical errors were evaluated by the bootstrap method(20) 
as shaded with pink in the Figure 4A. Movies S1-S4 were made from this calculation using 
UCSF Chimera(21). We repeated the same calculations for the recruitment of barr2 by pp-
µOR bound to DAMGO and TRV130 to assess the binding affinity. 
Modeling of pp-μOR-TRV130 in complex with the active barr2. 
To build the complex of barr2- pp-μOR-TRV130, we first matched TRV130 to the active 
conformation of human-μOR obtained from the GENSEMBLE calculation. Then, we 
superimposed the μOR-TRV130 complex to our optimized Gi-mouse-μOR-DAMGO(22) 
complex to build an activated state of Gi-μOR-TRV130. We immersed this complex in a 
POPC bilayer composed of 277 of POPC molecules and then solvated with ~32K water 
molecules. We neutralized the system and then added 0.15mM NaCl to maintain the 
biological salt concentration, which resulted to a simulation box of 101x101x146 Å3. 
Subsequently, we minimized the system with 2000 steps of steepest descents and 
subsequently equilibrated the complex by performing a 1.2ns of NVT followed by a 7ns of 
NPT simulation, where positional restraints were placed on the heavy atoms with a force 
constant of 9.6 kcal.mol-1.Å-2 which was gradually reduced to 0 kcal.mol-1.Å-2. We then 
performed another 80ns of NPT simulation, where we removed all restraints from the 
heavy atoms belonging to the protein while we kept strong restraints (2.4 kcal.mol-1.Å-2) 
on the heavy atoms of the TRV130. The purpose of this calculation was to allow the protein 
side chains to optimize and find the right interactions with the TRV130. Following that, 
we removed all restraints and performed a 240 ns of NPT simulation to relax the Gi- μOR-
TRV130 complex. Figure 5 was made using the results of this calculation.  
We then removed the Gi protein from our optimized Gi-μOR-TRV130 complex and 
immersed in this complex in a POPC bilayer composed of 164 of POPC molecules and 
then solvated with ~14K water molecules. We neutralized the system and then we added 
0.15mM NaCl to maintain the biological salt concentration, which resulted in a simulation 
box of 80x80x107 Å3. Subsequently, we minimized the system for 1000 steps of steepest 
descents and subsequently equilibrated the complex by performing a 1.0ns of NVT 
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followed by a 7ns of NPT simulation where positional restraints were placed on the heavy 
atoms with a force constant of 9.6 kcal.mol-1.Å-2 that was gradually reduced to 0 kcal.mol-
1.Å-2. We then performed another 400ns of NPT simulation, where we removed all 
restraints from the heavy atoms belonging to the protein while we kept strong restraints 
(2.4 kcal.mol-1.Å-2) on the heavy atoms of TRV130. The purpose of this calculation was to 
allow the intracellular and extracellular portions of the μOR to readjust in order to recruit 
barr2. Following that, we removed all restraints and performed a ~100ns of NPT simulation 
to relax the μOR-TRV130 complex.  
We subsequently used the optimized μOR-TRV130 complex and superimposed it to our 
optimized barr2-pp-μOR-DAMGO to add the pp-C tail and also to include the active state 
of barr2 into our model. We immersed the barr2-pp-μOR-TRV130 complex in a POPC 
bilayer composed of 356 of POPC molecules and then solvated with ~40K water 
molecules. We neutralized the system and then added 0.15mM NaCl to maintain the 
biological salt concentration, which resulted to a simulation box of 123x104x138 Å3. 
Subsequently, we minimized the system for 1200 steps of steepest descents and 
subsequently equilibrated the complex by performing 60ps of NVT followed by 650ps of 
NPT simulation where positional restraints were placed on the heavy atoms with a force 
constant of 9.6 kcal.mol-1.Å-2 and gradually reduced to 0 kcal.mol-1.Å-2. Finally, we 
removed all restraints and performed a 500 ns of NPT simulation. This was used to make 
Figure 6 in this paper.  
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Fig. S1. Activated structure of arrestin-1 mediated by pp-rhod refined by MD simulation. 
(A) The overall view of the pp-rhod-arrestin-1 after 450ns of MD simulation, leading to 
0.3Å RMSD (in respect to the Ca atoms) with the crystal structure (PDB ID: 5W0P), which 
are in excellent agreement. (B) Ionic interactions from arrestin-1 to the pp-C tail, where 
mostly involve between negatively charged residues on the C-tail residues and the 
positively charged residues on the N-domain of arrestin-1.   (C) Anchoring from R319 on 
the back loop to E239 on the ICL3 and also a salt bridge from K245 to D163. These strong 
interactions coordinate TM5 to couple with TM6 by forming a charge-charge interaction 
from K231 to E247. (D) Anchoring from D254 and S252 on the C-loop to K141 on the 
ICL2. Besides, we find that the finger loop interacts strongly with ICL1 by forming a salt 
bridge from D72 to K67 and also from Q70 to T70. Interestingly, the anchors on ICL2 and 
ICL3 formed in an opposite electrostatic arrangement, negative-positive attraction for the 
ICL3 and positive-negative attraction for the ICL2, compared to the activated barr2-pp-
µOR complex.  This may explain why pp-µOR does not intend to recruit the visual 
arrestins. 
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Fig. S2. Analysis of the conformation of the barr2 upon engaging the 7TM core of the pp-
µOR in the presence of DAMGO (full), morphine (partial), and TRV130 (biased) agonist for 
the coupling of the barr2. Superimposed N-domain of the active (obtained from our MD 
simulation) to the inactive (resolved in experiment, PDB 3PD2) state of the barr2 shows that 
the C-domain undergoes : (A) a ~18° twist relative to the N-domain in the presence of 
DAMGO; (D) a ~20° twist relative to the N-domain in the presence of morphine; (G ) a~19° 
twist relative to the N-domain in the presence of TRV130. 
Variation of the interdomain twist with time when the active conformation of the barr2 fully 
engages the pp-µOR bound to (B) DAMGO; (E) morphine; (H) TRV130. (C) Distribution of 
the interdomain twist angle once the active conformation of the barr2 binds the pp-µOR in 
the presence of (C) DAMGO; (F) morphine; (I) TRV130.  
(J) RMSD variation of the barr2-pp-µOR complex with time. Here, the RMSD for the 
backbone atoms of the whole structures over the course of simulation are compared to the 
initial trajectory.  
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Fig. S3. The comparison of the active conformation of the barr2 in complex with the pp-µOR 
bound to DAMGO (obtained from our MD simulation) with the experimentally resolved active 
conformation of: (A) barr2 (PDB:5TV1); (B) Arrestin-1 in the complex of pp-rhod1-arrestin-1 
(PDB:5W0P); (C) barr1 in the complex of pp-M2 muscarinic receptor-barr1 (PDB:6U1N); and 
(D) barr1 in the complex of pp-neurotensin receptor 1-barr1 (PDB:6UP7). 
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Fig. S4. The comparison between the experimentally resolved active conformation of barr2 
with the active conformation of the barr2 (obtained from our MD simulations) in complex with 
the pp-µOR bound to (A) morphine, and (B) TRV130. 
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Fig. S5. Phosphorylated human μOR-barr2-morphine complex immersed in the lipid bilayer 
depicted. Here, we eliminated the lipid anchoring from the C-edge. Cartoon views colored by 
subunit: blue, pp-μOR; Orange, -barr2; magenta, MP1104; green, pp-C tail; sky blue dots, 
water; yellow, POPC. This system contains 356 POPC molecules, ~40K water molecules, and 
excess 0.15mM of NaCl counterions. 
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Fig. S6. (A) The high affinity barr2-pp-µOR-morphine complex immersed in the membrane 
bilayer obtained independently form the second 500 ns of MD simulation. (B) The polar 
anchor from the barr2 to ICL2 of the µOR, which creates a polar network of interactions from 
the finger loop to ICL2 and the cytosolic end of TM2. (E) polar anchors from the barr2 to both 
ICL3 and the bottom end of TM6, fully engaging the body of the barr2 to the core of the µOR. 
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Fig. S7. Process of forming the fully engaged complex between the pp-μOR and the 
barr2 in the presence of DAMGO. (A) The averaged PMF indicates that the recruited 
barr2 by the pp-C tail spontaneously couples the core of pp-μOR. The free energy was 
obtained by umbrella sampling, where the reaction coordinate is the distance along the 
z-component between the center of mass of Cas in the pp-µOR for residues 54-340 and 
the center of mass of Cas in barr2. The errors were shown as shaded profile in light 
green. (B) Sequence of important events in the recruitment of the barr2 by the pp-μOR 
bound to DAMGO. Our free energy calculation suggests the following pathway; i) S-I: 
the barr2 couples to the pp-C tail of μOR, involving mainly salt bridges from pS and pT 
residues to positively charged residues on the N-domain of the barr2; ii) S-II: the 
flexible finger loop extends to the receptor core to engage the ICL2 by forming a salt 
bridge from R66 to D179; iii) S-III: the extended finger loop induces D179 to form an 
ionic anchor with R286Back loop. iv) S-IV: anchoring to the ICL2 allows the rest of barr2 
to ascend to form two anchors from E314 to R265 on the ICL3 and from D79 to 
K2736.26. This free energy calculation indicates that the finger loop is a main driver of 
the barr2 coupling to the 7TM core of pp-µOR. 
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Fig. S8. Process of forming the fully engaged complex between the pp-μOR and the 
barr2 in the presence of TRV130. (A) The averaged PMF indicates that the recruited 
barr2 by the pp-C tail spontaneously couples the core of pp-μOR. The free energy was 
obtained by umbrella sampling, where the reaction coordinate is the distance along the 
z-component between the center of mass of Cas in the pp-µOR for residues 54-340 and 
the center of mass of Cas in barr2. The errors were shown as shaded profile in pink. 
(B) Sequence of important events in the recruitment of the barr2 by the pp-μOR bound 
to TRV130. Our free energy calculation suggests the following pathway; i) S-I: the 
barr2 couples to the pp-C tail of μOR, involving mainly salt bridges from pS and pT 
residues to positively charged residues on the N-domain of the barr2; ii) S-II: the 
flexible finger loop extends to the receptor core to engage the ICL2 by forming a salt 
bridge from D68 to R181; iii) S-III: the extended finger loop moves toward the ICL1 to 
form an additional salt bridge from E67 to K102ICL2. Anchoring to the ICL1 allows 
the rest of barr2 to ascend to form an ionic anchor from R286 on the C-loop to D179 on 
the ICL2. Our free energy calculation for the third case study confirms that the finger 
loop is a main driver of the barr2 coupling to the 7TM core of pp-µOR. 
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Fig. S9. Optimization of pp-C tail conformation in complex with inactive state of barr2 using 
metaMD simulations. Calculated affinity free energy profile by metaMD for interactions: (B) 
pT396(P)-R95barr2(CZ); (D) pT372 (P)-R47barr2(CZ); (F) pS365(P)-K13barr2(NZ); (H) 
pS377(P)-K13barr2(NZ); (J) pT385(P)-K6barr2(NZ); (L) pT372 (P)-R47barr2(CZ); (N) 
pT372 (P)-K148barr2(NZ); (P) pS358(P)-K153barr2(NZ). Variations of interactions with 
time between (A) pT396(P)-R95barr2(CZ); (C) pT372 (P)-R47barr2(CZ); (E) pS365(P)-
K13barr2(NZ); (G) pS377(P)-K13barr2(NZ); (I) pT385(P)-K6barr2(NZ); (K) pT372 (P)-
R47barr2(CZ); (M) pT372 (P)-K148barr2(NZ); (O) pS358(P)-K153barr2(NZ). 
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Table S1. List of metaMD simulation along with the conditions used to evaluate free 
energies to optimize the conformation of pp-C tail in the presence of inactive state of 
barr2. 
Calculation 
# 
Duration 
(ns) 
Reaction 
coordinate 
(Å) 
Initial 
value 
(Å) 
Starting 
point (ns) 
MetaMD 
parameters Restraint 
1 87.5 pT396(P)-R95barr2(CZ) 25.6 - 
Hills 
height=0.6 
kcal.mol-
1,s=1Å, Bias 
factor=20 
D179(CG)-K134 barr2 (NZ) 
2 89.3 pT372 (P)-R47barr2(CZ) 18.1 
~69.7 
(from #1) 
Hills 
height=0.6 
kcal.mol-
1,s=1Å, Bias 
factor=20 
1) D179(CG)-K134 barr2 
(NZ) 
2) pT396(P)-R95barr2 (CZ) 
3 28.7 pS365(P)-K13barr2(NZ) 10.3 
~26.1 
(from #2) 
Hills 
height=0.6 
kcal.mol-
1,s=1Å, Bias 
factor=20 
1) D179(CG)-K134 barr2 
(NZ) 
2) pT396(P)-R95barr2 (CZ) 
4 46.0 pS377(P)-K13barr2(NZ) 8.6 
~26.1 
(from #3) 
Hills 
height=0.6 
kcal.mol-
1,s=0.5Å, 
Bias 
factor=20 
1) D179(CG)-K134 barr2 
(NZ) 
2) pT396(P)-R95barr2 (CZ) 
5 44.2 pT385(P)-K6barr2(NZ) 18.7 
~32.8 
(from #4) 
Hills 
height=0.6 
kcal.mol-
1,s=0.5Å, 
Bias 
factor=20 
1) D179(CG)-K134 barr2 
(NZ) 
2) pT396(P)-R95barr2 (CZ) 
6 26.5 pT372 (P)-R47barr2(CZ) 15.3 
~35.2 
(from #5) 
Hills 
height=0.6 
kcal.mol-
1,s=0.5Å, 
Bias 
factor=20 
1) D179(CG)-K134 barr2 
(NZ) 
2) pT396(P)-R95barr2 (CZ) 
3) pT385(P)-K6barr2(NZ) 
7 31.0 pT372 (P)-K148barr2(NZ) 12.9 
~26.4 
(from #6) 
Hills 
height=0.6 
kcal.mol-
1,s=0.5Å, 
Bias 
factor=20 
1) D179(CG)-K134 barr2 
(NZ) 
2) pT396(P)-R95barr2 (CZ) 
3) pT385(P)-K6barr2(NZ) 
8 24.5 pS358(P)-K153barr2(NZ) 13.0 
~30.2(from 
#7) 
Hills 
height=0.6 
kcal.mol-
1,s=0.5Å, 
Bias 
factor=20 
1) D179(CG)-K134 barr2 
(NZ) 
2) pT396(P)-R95barr2 (CZ) 
3) pT385(P)-K6barr2(NZ) 
4) pT372 (P)-K148barr2(NZ) 
5) pT372 (P)-R47barr2(CZ) 
6) pS377(P)-K13barr2(NZ) 
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Movie S1 (separate file). barr2 recruitment by pp-μOR and morphine.   
Movie S2 (separate file). Finger loop as a major driver of barr2 coupling to the core pp-µOR. 
Movie S3 (separate file). Emergence of polar anchor between barr2 and ICL3 of pp-μOR. 
Movie S4 (separate file). Emergence of polar anchor between barr2 and ICL2 of pp-μOR. 
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